NewEdge Advisors’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$248K Buy
16,659
+15,634
+1,525% +$168K ﹤0.01% 2627
2026
Q1
$8.67K Hold
1,025
﹤0.01% 3439
2025
Q4
$11.6K Buy
1,025
+25
+3% +$310 ﹤0.01% 3426
2025
Q3
$15K Buy
+1,000
New +$14.6K ﹤0.01% 3215
2024
Q2
Sell
-55
Closed -$3.01K 3809
2024
Q1
$3.01K Sell
55
-27
-33% -$1.34K ﹤0.01% 3289
2023
Q4
$3.51K Hold
82
﹤0.01% 3219
2023
Q3
$2.13K Sell
82
-2
-2% -$42 ﹤0.01% 3029
2023
Q2
$2.01K Sell
84
-72
-46% -$1.24K ﹤0.01% 3094
2023
Q1
$2.13K Sell
156
-4,964
-97% -$79K ﹤0.01% 3018
2022
Q4
$21.8K Buy
+5,120
New +$72.3K ﹤0.01% 2095

Other funds holding BHVN

NewEdge Advisors's BHVN Position: Q2 2026 in Review

NewEdge Advisors increased its Biohaven (BHVN) stake by 1,525% in Q2 2026, buying an estimated $168K and bringing the position to 16,659 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #2627.

NewEdge Advisors first reported a position in BHVN in Q4 2022 and has held it in 10 quarters since. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • NewEdge Advisors held 16,659 shares of Biohaven worth $248K as of Q2 2026.
  • NewEdge Advisors bought 15,634 Biohaven shares in Q2 2026, an estimated $168K.
  • Biohaven made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #2627 holding.
  • NewEdge Advisors first reported a position in Biohaven in Q4 2022 and has held it in 10 quarters since.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.